Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

[SAMHD1 deprives HIV of nucleotides, essential for viral DNA synthesis].

Lahouassa H, Dragin L, Transy C, Margottin-Goguet F.

Med Sci (Paris). 2012 Nov;28(11):909-10. doi: 10.1051/medsci/20122811002. Epub 2012 Nov 12. French. No abstract available.

2.

SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F.

Nat Immunol. 2012 Feb 12;13(3):223-228. doi: 10.1038/ni.2236. Erratum in: Nat Immunol. 2013 Aug;14(8):877.

3.

Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.

Maudet C, Bertrand M, Le Rouzic E, Lahouassa H, Ayinde D, Nisole S, Goujon C, Cimarelli A, Margottin-Goguet F, Transy C.

J Biol Chem. 2011 Jul 8;286(27):23742-52. doi: 10.1074/jbc.M111.220780. Epub 2011 May 12.

4.

Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Ayinde D, Maudet C, Transy C, Margottin-Goguet F.

Retrovirology. 2010 Apr 9;7:35. doi: 10.1186/1742-4690-7-35. Review.

5.

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.

Transy C, Margottin-Goguet F.

Cell Cycle. 2009 Aug 15;8(16):2489-90. No abstract available.

PMID:
19667756
6.

Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.

Bui LC, Tomkiewicz C, Chevallier A, Pierre S, Bats AS, Mota S, Raingeaud J, Pierre J, Diry M, Transy C, Garlatti M, Barouki R, Coumoul X.

Oncogene. 2009 Oct 15;28(41):3642-51. doi: 10.1038/onc.2009.224. Epub 2009 Aug 3.

PMID:
19648964
7.

Human TRIM gene expression in response to interferons.

Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S.

PLoS One. 2009;4(3):e4894. doi: 10.1371/journal.pone.0004894. Epub 2009 Mar 17.

8.

The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection.

Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, Descamps D, Damond F, Brun-Vezinet F, Nisole S, Margottin-Goguet F, Pancino G, Transy C.

J Virol. 2009 May;83(10):4854-60. doi: 10.1128/JVI.00187-09. Epub 2009 Mar 4.

9.

Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.

Le Rouzic E, Morel M, Ayinde D, Belaïdouni N, Letienne J, Transy C, Margottin-Goguet F.

J Biol Chem. 2008 Aug 1;283(31):21686-92. doi: 10.1074/jbc.M710298200. Epub 2008 Jun 4.

10.

Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.

Estrabaud E, Le Rouzic E, Lopez-Vergès S, Morel M, Belaïdouni N, Benarous R, Transy C, Berlioz-Torrent C, Margottin-Goguet F.

PLoS Pathog. 2007 Jul 27;3(7):e104.

11.

HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.

Le Rouzic E, Belaïdouni N, Estrabaud E, Morel M, Rain JC, Transy C, Margottin-Goguet F.

Cell Cycle. 2007 Jan 15;6(2):182-8. Epub 2007 Jan 17.

PMID:
17314515
12.

Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell plasticity through a JNK-dependent mechanism.

Diry M, Tomkiewicz C, Koehle C, Coumoul X, Bock KW, Barouki R, Transy C.

Oncogene. 2006 Sep 7;25(40):5570-4. Epub 2006 Apr 17.

PMID:
16619036
13.

In vivo hierarchy of immunodominant and subdominant HLA-A*0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus.

Malmassari S, Lone YC, Zhang M, Transy C, Michel ML.

Microbes Infect. 2005 Apr;7(4):626-34. Epub 2005 Mar 16.

PMID:
15820153
14.
15.

Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex.

Bergametti F, Sitterlin D, Transy C.

J Virol. 2002 Jul;76(13):6495-501.

16.

Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses.

Sitterlin D, Bergametti F, Tiollais P, Tennant BC, Transy C.

Oncogene. 2000 Sep 7;19(38):4427-31.

17.

UVDDB p127-binding modulates activities and intracellular distribution of hepatitis B virus X protein.

Sitterlin D, Bergametti F, Transy C.

Oncogene. 2000 Sep 7;19(38):4417-26.

18.

A genomic approach of the hepatitis C virus generates a protein interaction map.

Flajolet M, Rotondo G, Daviet L, Bergametti F, Inchauspé G, Tiollais P, Transy C, Legrain P.

Gene. 2000 Jan 25;242(1-2):369-79.

PMID:
10721731
19.

The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines.

Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C.

Oncogene. 1999 May 6;18(18):2860-71.

20.
21.

Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment.

Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7316-21.

23.

The bifunctional DCOH protein binds to HNF1 independently of its 4-alpha-carbinolamine dehydratase activity.

Sourdive DJ, Transy C, Garbay S, Yaniv M.

Nucleic Acids Res. 1997 Apr 15;25(8):1476-84.

24.
25.

A functional N-myc2 retroposon in ground squirrels: implications for hepadnavirus-associated carcinogenesis.

Quignon F, Renard CA, Tiollais P, Buendia MA, Transy C.

Oncogene. 1996 May 2;12(9):2011-7.

PMID:
8649862
26.

The two-hybrid: an in vivo protein-protein interaction assay.

Transy C, Legrain P.

Mol Biol Rep. 1995;21(2):119-27. No abstract available.

PMID:
8531922
27.

Detection of protein-protein interactions using different vectors in the two-hybrid system.

Legrain P, Dokhelar MC, Transy C.

Nucleic Acids Res. 1994 Aug 11;22(15):3241-2. No abstract available.

28.
29.

Expression of the woodchuck N-myc2 retroposon in brain and in liver tumors is driven by a cryptic N-myc promoter.

Fourel G, Transy C, Tennant BC, Buendia MA.

Mol Cell Biol. 1992 Dec;12(12):5336-44.

30.

Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.

Transy C, Fourel G, Robinson WS, Tiollais P, Marion PL, Buendia MA.

Proc Natl Acad Sci U S A. 1992 May 1;89(9):3874-8.

31.

Antibody-induced mitogenicity mediated by a chimeric CD2-c-fms receptor.

Roussel MF, Transy C, Kato JY, Reinherz EL, Sherr CJ.

Mol Cell Biol. 1990 May;10(5):2407-12.

32.

A new cell surface molecule closely related to mouse class I transplantation antigens.

Cochet M, Casrouge A, Dumont AM, Transy C, Baleux F, Maloy WL, Coligan JE, Cazenave PA, Kourilsky P.

Eur J Immunol. 1989 Oct;19(10):1927-31.

PMID:
2583228
33.

Deletion of the cytoplasmic region of the CD3 epsilon subunit does not prevent assembly of a functional T-cell receptor.

Transy C, Moingeon P, Stebbins C, Reinherz EL.

Proc Natl Acad Sci U S A. 1989 Sep;86(18):7108-12.

34.

Most anti-human CD3 monoclonal antibodies are directed to the CD3 epsilon subunit.

Transy C, Moingeon PE, Marshall B, Stebbins C, Reinherz EL.

Eur J Immunol. 1989 May;19(5):947-50.

PMID:
2472280
35.

Expression of a functional CD3-Ti antigen/MHC receptor in the absence of surface CD2. Analysis with clonal Jurkat cell mutants.

Moingeon P, Alcover A, Clayton LK, Chang HC, Transy C, Reinherz EL.

J Exp Med. 1988 Dec 1;168(6):2077-90.

36.

Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.

Alcover A, Alberini C, Acuto O, Clayton LK, Transy C, Spagnoli GC, Moingeon P, Lopez P, Reinherz EL.

EMBO J. 1988 Jul;7(7):1973-7.

37.

A low polymorphic mouse H-2 class I gene from the Tla complex is expressed in a broad variety of cell types.

Transy C, Nash SR, David-Watine B, Cochet M, Hunt SW 3rd, Hood LE, Kourilsky P.

J Exp Med. 1987 Aug 1;166(2):341-61.

38.

Tissue-specific expression of the mouse Q10 H-2 class-I gene during embryogenesis.

David-Watine B, Transy C, Gachelin G, Kourilsky P.

Gene. 1987;61(2):145-54.

PMID:
3443306
39.

A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.

Baldacci P, Transy C, Cochet M, Penit C, Israel A, Kourilsky P.

J Exp Med. 1986 Sep 1;164(3):677-94.

40.

Alternative splicing in the mouse H-2Kd gene is not necessary for the classical Kd antigen function.

Cochet M, Kast WM, Kummer AM, Transy C, Melief CJ, Kourilsky P.

Immunogenetics. 1986;24(4):267-74.

PMID:
3491042
41.

Expression of class I genes in the major histocompatibility complex: identification of eight distinct mRNAs in DBA/2 mouse liver.

Lalanne JL, Transy C, Guerin S, Darche S, Meulien P, Kourilsky P.

Cell. 1985 Jun;41(2):469-78.

PMID:
3838699
42.

Alternative splicing in the 5' moiety of the H-2Kd gene transcript.

Transy C, Lalanne JL, Kourilsky P.

EMBO J. 1984 Oct;3(10):2383-6.

43.

Functional expression of a mouse H-2Kb gene isolated from non-expressing teratocarcinoma cells.

Daniel-Vedele F, Morello D, Benicourt C, Transy C, Le Bail O, Plata F, Kourilsky P.

EMBO J. 1984 Mar;3(3):597-601.

44.

Effect of "facteur thymique sérique" (FTS) on TdT expression in murine thymocytes.

Gelabert MJ, Transy C, Penit C.

Cell Immunol. 1982 Jul 15;71(1):118-26. No abstract available.

PMID:
6982760
45.

Purification and properties of chick terminal deoxynucleotidyl transferase (TdT).

Pénit C, Gelabert MJ, Transy C, Rouget P.

Adv Exp Med Biol. 1982;145:61-73. No abstract available.

PMID:
7051783
46.

Hybrids between myeloma cells and thymocytes - and attempt to approach the biological function of terminal transferase.

Transy C, Rouget P.

Adv Exp Med Biol. 1982;145:207-19. No abstract available.

PMID:
6981291

Supplemental Content

Loading ...
Support Center